819 articles
Allitia DiBernardo, MD, Global Head of Medical Affairs-Neuroscience at Janssen discusses a presentation at the 2021 European Committee for Treatment and...
Adam Feldman, MD, MPH, urologic oncologist at the Massachusetts General Hospital Department of Urology discusses his presentation from the 2021 American...
CU cancer center member Dan Pollyea, MD, MS, clinical director of leukemia services at the University of Colorado School of Medicine, discusses navigati...
shares her journey battling HER2-positive metastatic breast cancer and her experience enrolled in the HER2CLIMB clinical trial. She is joined by her p...
Ifeyinwa Stitt, MD, Board Certified OBGYN discusses the first ever genetic assessment tool for ALL women to better understand their risk for breast canc...
Ginna Laport, VP and Global Head of Lymphoma at Genentech discusses types of blood cancers, the historic treatment challenges, and new research and trea...
Doreen Ezeife, MD, FRCPC, Staff Medical Oncologist at the Tom Baker Cancer Centre in Calgary, Alberta discusses new data presented at the International ...
September is Desmoid Tumor Awareness Month, and given that nearly 30% to 40% of desmoid tumors are initially misdiagnosed, partly due to a lack of aware...
The COVID-19 Delta variant is raging through the US putting patients on hemodialysis (HD) at higher risk for infection. Learn more on Health Professional Radio.
Shannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago.